Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Oncology and Molecular Targeting in Advanced Genitourinary Cancers: Identifying Predictive Markers of Response (The "PROMOTE" Study)

NCT02735252 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02735252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02735252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Oncology and Molecular Targeting in Advanced Genitourinary Cancers: Identifying Predictive Markers of Response (The "PROMOTE" Study)
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 25, 2016
Completion date
March 31, 2027
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced renal cell carcinoma, advanced urothelial carcinoma, genitourinary cancer, prostate cancer